Overall, ISV with FOLactis could induce tumor regression mainly dependent on CD8+ T and NK cells, with other immune cell subsets, such as macrophages and CD4+ T cells, playing lesser roles in tumor rejection. This evidence concerns the gene CD8A and neoplasm.